Global Non-recombinant Coagulation Factors Market Growth 2026-2032
The global Non-recombinant Coagulation Factors market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.
United States market for Non-recombinant Coagulation Factors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-recombinant Coagulation Factors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-recombinant Coagulation Factors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-recombinant Coagulation Factors players cover Takeda Pharmaceutical, Instituto Grifols SA, CSL Behring LLC, KM Biologics KK, Baxter Healthcare Corp., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Non-recombinant Coagulation Factors Industry Forecast” looks at past sales and reviews total world Non-recombinant Coagulation Factors sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-recombinant Coagulation Factors sales for 2026 through 2032. With Non-recombinant Coagulation Factors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-recombinant Coagulation Factors industry.
This Insight Report provides a comprehensive analysis of the global Non-recombinant Coagulation Factors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-recombinant Coagulation Factors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-recombinant Coagulation Factors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-recombinant Coagulation Factors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-recombinant Coagulation Factors.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-recombinant Coagulation Factors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Non-recombinant coagulation factors refer to coagulation factors synthesized by the human body itself, which are different from coagulation factors synthesized through genetic recombination technology (recombinant coagulation factors). These coagulation factors are synthesized by the liver and other tissues of the human body under normal circumstances and play an important role in the coagulation process, helping to stop bleeding and maintain blood coagulation balance. Non-recombinant clotting factors are usually obtained from blood donations from healthy people.
United States market for Non-recombinant Coagulation Factors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Non-recombinant Coagulation Factors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Non-recombinant Coagulation Factors is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Non-recombinant Coagulation Factors players cover Takeda Pharmaceutical, Instituto Grifols SA, CSL Behring LLC, KM Biologics KK, Baxter Healthcare Corp., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Non-recombinant Coagulation Factors Industry Forecast” looks at past sales and reviews total world Non-recombinant Coagulation Factors sales in 2025, providing a comprehensive analysis by region and market sector of projected Non-recombinant Coagulation Factors sales for 2026 through 2032. With Non-recombinant Coagulation Factors sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-recombinant Coagulation Factors industry.
This Insight Report provides a comprehensive analysis of the global Non-recombinant Coagulation Factors landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-recombinant Coagulation Factors portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Non-recombinant Coagulation Factors market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-recombinant Coagulation Factors and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-recombinant Coagulation Factors.
This report presents a comprehensive overview, market shares, and growth opportunities of Non-recombinant Coagulation Factors market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Coagulation Factor VIII
- Human Fibrinogen
- Others
- Hemophilia
- Fibrinogen Deficiency
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Takeda Pharmaceutical
- Instituto Grifols SA
- CSL Behring LLC
- KM Biologics KK
- Baxter Healthcare Corp.
- Sanquin
- Johnson & Johnson
- Octapharma AG
- Bio Products Laboratory Ltd.
- Grifols Biologicals, Inc.
- Pfizer Inc.
- Intas Biopharmaceuticals Ltd.
- Shandong Taibang Biological Products
- Sinopharm Group Shanghai Blood Products
- SHANGHAI RAAS
- China Resources Boya Bio-Pharmaceutical
- Chengdu Rongsheng Pharmaceuticals
- Yuanda Shuyang Pharmaceutical
- HUALAN BIO
- What is the 10-year outlook for the global Non-recombinant Coagulation Factors market?
- What factors are driving Non-recombinant Coagulation Factors market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Non-recombinant Coagulation Factors market opportunities vary by end market size?
- How does Non-recombinant Coagulation Factors break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-recombinant Coagulation Factors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-recombinant Coagulation Factors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-recombinant Coagulation Factors by Country/Region, 2021, 2025 & 2032
2.2 Non-recombinant Coagulation Factors Segment by Type
2.2.1 Coagulation Factor VIII
2.2.2 Human Fibrinogen
2.2.3 Others
2.2.4 Non-recombinant Coagulation Factors Sales by Type
2.2.4.1 Global Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-recombinant Coagulation Factors Sale Price by Type (2021-2026)
2.3 Non-recombinant Coagulation Factors Segment by Application
2.3.1 Hemophilia
2.3.2 Fibrinogen Deficiency
2.3.3 Other
2.3.4 Non-recombinant Coagulation Factors Sales by Application
2.3.4.1 Global Non-recombinant Coagulation Factors Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-recombinant Coagulation Factors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-recombinant Coagulation Factors Breakdown Data by Company
3.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Company (2021-2026)
3.1.2 Global Non-recombinant Coagulation Factors Sales Market Share by Company (2021-2026)
3.2 Global Non-recombinant Coagulation Factors Annual Revenue by Company (2021-2026)
3.2.1 Global Non-recombinant Coagulation Factors Revenue by Company (2021-2026)
3.2.2 Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2021-2026)
3.3 Global Non-recombinant Coagulation Factors Sale Price by Company
3.4 Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-recombinant Coagulation Factors Product Location Distribution
3.4.2 Players Non-recombinant Coagulation Factors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
4.1 World Historic Non-recombinant Coagulation Factors Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-recombinant Coagulation Factors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-recombinant Coagulation Factors Market Size by Country/Region (2021-2026)
4.2.1 Global Non-recombinant Coagulation Factors Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-recombinant Coagulation Factors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-recombinant Coagulation Factors Sales Growth
4.4 APAC Non-recombinant Coagulation Factors Sales Growth
4.5 Europe Non-recombinant Coagulation Factors Sales Growth
4.6 Middle East & Africa Non-recombinant Coagulation Factors Sales Growth
5 AMERICAS
5.1 Americas Non-recombinant Coagulation Factors Sales by Country
5.1.1 Americas Non-recombinant Coagulation Factors Sales by Country (2021-2026)
5.1.2 Americas Non-recombinant Coagulation Factors Revenue by Country (2021-2026)
5.2 Americas Non-recombinant Coagulation Factors Sales by Type (2021-2026)
5.3 Americas Non-recombinant Coagulation Factors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-recombinant Coagulation Factors Sales by Region
6.1.1 APAC Non-recombinant Coagulation Factors Sales by Region (2021-2026)
6.1.2 APAC Non-recombinant Coagulation Factors Revenue by Region (2021-2026)
6.2 APAC Non-recombinant Coagulation Factors Sales by Type (2021-2026)
6.3 APAC Non-recombinant Coagulation Factors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-recombinant Coagulation Factors by Country
7.1.1 Europe Non-recombinant Coagulation Factors Sales by Country (2021-2026)
7.1.2 Europe Non-recombinant Coagulation Factors Revenue by Country (2021-2026)
7.2 Europe Non-recombinant Coagulation Factors Sales by Type (2021-2026)
7.3 Europe Non-recombinant Coagulation Factors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-recombinant Coagulation Factors by Country
8.1.1 Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-recombinant Coagulation Factors Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-recombinant Coagulation Factors Sales by Type (2021-2026)
8.3 Middle East & Africa Non-recombinant Coagulation Factors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors
10.3 Manufacturing Process Analysis of Non-recombinant Coagulation Factors
10.4 Industry Chain Structure of Non-recombinant Coagulation Factors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-recombinant Coagulation Factors Distributors
11.3 Non-recombinant Coagulation Factors Customer
12 WORLD FORECAST REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
12.1 Global Non-recombinant Coagulation Factors Market Size Forecast by Region
12.1.1 Global Non-recombinant Coagulation Factors Forecast by Region (2027-2032)
12.1.2 Global Non-recombinant Coagulation Factors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-recombinant Coagulation Factors Forecast by Type (2027-2032)
12.7 Global Non-recombinant Coagulation Factors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Instituto Grifols SA
13.2.1 Instituto Grifols SA Company Information
13.2.2 Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Instituto Grifols SA Main Business Overview
13.2.5 Instituto Grifols SA Latest Developments
13.3 CSL Behring LLC
13.3.1 CSL Behring LLC Company Information
13.3.2 CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring LLC Main Business Overview
13.3.5 CSL Behring LLC Latest Developments
13.4 KM Biologics KK
13.4.1 KM Biologics KK Company Information
13.4.2 KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.4.3 KM Biologics KK Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 KM Biologics KK Main Business Overview
13.4.5 KM Biologics KK Latest Developments
13.5 Baxter Healthcare Corp.
13.5.1 Baxter Healthcare Corp. Company Information
13.5.2 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Baxter Healthcare Corp. Main Business Overview
13.5.5 Baxter Healthcare Corp. Latest Developments
13.6 Sanquin
13.6.1 Sanquin Company Information
13.6.2 Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.6.3 Sanquin Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sanquin Main Business Overview
13.6.5 Sanquin Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Octapharma AG
13.8.1 Octapharma AG Company Information
13.8.2 Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.8.3 Octapharma AG Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Octapharma AG Main Business Overview
13.8.5 Octapharma AG Latest Developments
13.9 Bio Products Laboratory Ltd.
13.9.1 Bio Products Laboratory Ltd. Company Information
13.9.2 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Bio Products Laboratory Ltd. Main Business Overview
13.9.5 Bio Products Laboratory Ltd. Latest Developments
13.10 Grifols Biologicals, Inc.
13.10.1 Grifols Biologicals, Inc. Company Information
13.10.2 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Grifols Biologicals, Inc. Main Business Overview
13.10.5 Grifols Biologicals, Inc. Latest Developments
13.11 Pfizer Inc.
13.11.1 Pfizer Inc. Company Information
13.11.2 Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Pfizer Inc. Main Business Overview
13.11.5 Pfizer Inc. Latest Developments
13.12 Intas Biopharmaceuticals Ltd.
13.12.1 Intas Biopharmaceuticals Ltd. Company Information
13.12.2 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Intas Biopharmaceuticals Ltd. Main Business Overview
13.12.5 Intas Biopharmaceuticals Ltd. Latest Developments
13.13 Shandong Taibang Biological Products
13.13.1 Shandong Taibang Biological Products Company Information
13.13.2 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shandong Taibang Biological Products Main Business Overview
13.13.5 Shandong Taibang Biological Products Latest Developments
13.14 Sinopharm Group Shanghai Blood Products
13.14.1 Sinopharm Group Shanghai Blood Products Company Information
13.14.2 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sinopharm Group Shanghai Blood Products Main Business Overview
13.14.5 Sinopharm Group Shanghai Blood Products Latest Developments
13.15 SHANGHAI RAAS
13.15.1 SHANGHAI RAAS Company Information
13.15.2 SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 SHANGHAI RAAS Main Business Overview
13.15.5 SHANGHAI RAAS Latest Developments
13.16 China Resources Boya Bio-Pharmaceutical
13.16.1 China Resources Boya Bio-Pharmaceutical Company Information
13.16.2 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 China Resources Boya Bio-Pharmaceutical Main Business Overview
13.16.5 China Resources Boya Bio-Pharmaceutical Latest Developments
13.17 Chengdu Rongsheng Pharmaceuticals
13.17.1 Chengdu Rongsheng Pharmaceuticals Company Information
13.17.2 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Chengdu Rongsheng Pharmaceuticals Main Business Overview
13.17.5 Chengdu Rongsheng Pharmaceuticals Latest Developments
13.18 Yuanda Shuyang Pharmaceutical
13.18.1 Yuanda Shuyang Pharmaceutical Company Information
13.18.2 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Yuanda Shuyang Pharmaceutical Main Business Overview
13.18.5 Yuanda Shuyang Pharmaceutical Latest Developments
13.19 HUALAN BIO
13.19.1 HUALAN BIO Company Information
13.19.2 HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.19.3 HUALAN BIO Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 HUALAN BIO Main Business Overview
13.19.5 HUALAN BIO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Non-recombinant Coagulation Factors Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Non-recombinant Coagulation Factors by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Non-recombinant Coagulation Factors by Country/Region, 2021, 2025 & 2032
2.2 Non-recombinant Coagulation Factors Segment by Type
2.2.1 Coagulation Factor VIII
2.2.2 Human Fibrinogen
2.2.3 Others
2.2.4 Non-recombinant Coagulation Factors Sales by Type
2.2.4.1 Global Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
2.2.4.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Non-recombinant Coagulation Factors Sale Price by Type (2021-2026)
2.3 Non-recombinant Coagulation Factors Segment by Application
2.3.1 Hemophilia
2.3.2 Fibrinogen Deficiency
2.3.3 Other
2.3.4 Non-recombinant Coagulation Factors Sales by Application
2.3.4.1 Global Non-recombinant Coagulation Factors Sale Market Share by Application (2021-2026)
2.3.4.2 Global Non-recombinant Coagulation Factors Revenue and Market Share by Application (2021-2026)
2.3.4.3 Global Non-recombinant Coagulation Factors Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Non-recombinant Coagulation Factors Breakdown Data by Company
3.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Company (2021-2026)
3.1.2 Global Non-recombinant Coagulation Factors Sales Market Share by Company (2021-2026)
3.2 Global Non-recombinant Coagulation Factors Annual Revenue by Company (2021-2026)
3.2.1 Global Non-recombinant Coagulation Factors Revenue by Company (2021-2026)
3.2.2 Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2021-2026)
3.3 Global Non-recombinant Coagulation Factors Sale Price by Company
3.4 Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Non-recombinant Coagulation Factors Product Location Distribution
3.4.2 Players Non-recombinant Coagulation Factors Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
4.1 World Historic Non-recombinant Coagulation Factors Market Size by Geographic Region (2021-2026)
4.1.1 Global Non-recombinant Coagulation Factors Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Non-recombinant Coagulation Factors Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Non-recombinant Coagulation Factors Market Size by Country/Region (2021-2026)
4.2.1 Global Non-recombinant Coagulation Factors Annual Sales by Country/Region (2021-2026)
4.2.2 Global Non-recombinant Coagulation Factors Annual Revenue by Country/Region (2021-2026)
4.3 Americas Non-recombinant Coagulation Factors Sales Growth
4.4 APAC Non-recombinant Coagulation Factors Sales Growth
4.5 Europe Non-recombinant Coagulation Factors Sales Growth
4.6 Middle East & Africa Non-recombinant Coagulation Factors Sales Growth
5 AMERICAS
5.1 Americas Non-recombinant Coagulation Factors Sales by Country
5.1.1 Americas Non-recombinant Coagulation Factors Sales by Country (2021-2026)
5.1.2 Americas Non-recombinant Coagulation Factors Revenue by Country (2021-2026)
5.2 Americas Non-recombinant Coagulation Factors Sales by Type (2021-2026)
5.3 Americas Non-recombinant Coagulation Factors Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Non-recombinant Coagulation Factors Sales by Region
6.1.1 APAC Non-recombinant Coagulation Factors Sales by Region (2021-2026)
6.1.2 APAC Non-recombinant Coagulation Factors Revenue by Region (2021-2026)
6.2 APAC Non-recombinant Coagulation Factors Sales by Type (2021-2026)
6.3 APAC Non-recombinant Coagulation Factors Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Non-recombinant Coagulation Factors by Country
7.1.1 Europe Non-recombinant Coagulation Factors Sales by Country (2021-2026)
7.1.2 Europe Non-recombinant Coagulation Factors Revenue by Country (2021-2026)
7.2 Europe Non-recombinant Coagulation Factors Sales by Type (2021-2026)
7.3 Europe Non-recombinant Coagulation Factors Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Non-recombinant Coagulation Factors by Country
8.1.1 Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2021-2026)
8.1.2 Middle East & Africa Non-recombinant Coagulation Factors Revenue by Country (2021-2026)
8.2 Middle East & Africa Non-recombinant Coagulation Factors Sales by Type (2021-2026)
8.3 Middle East & Africa Non-recombinant Coagulation Factors Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors
10.3 Manufacturing Process Analysis of Non-recombinant Coagulation Factors
10.4 Industry Chain Structure of Non-recombinant Coagulation Factors
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Non-recombinant Coagulation Factors Distributors
11.3 Non-recombinant Coagulation Factors Customer
12 WORLD FORECAST REVIEW FOR NON-RECOMBINANT COAGULATION FACTORS BY GEOGRAPHIC REGION
12.1 Global Non-recombinant Coagulation Factors Market Size Forecast by Region
12.1.1 Global Non-recombinant Coagulation Factors Forecast by Region (2027-2032)
12.1.2 Global Non-recombinant Coagulation Factors Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Non-recombinant Coagulation Factors Forecast by Type (2027-2032)
12.7 Global Non-recombinant Coagulation Factors Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Takeda Pharmaceutical
13.1.1 Takeda Pharmaceutical Company Information
13.1.2 Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.1.3 Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Takeda Pharmaceutical Main Business Overview
13.1.5 Takeda Pharmaceutical Latest Developments
13.2 Instituto Grifols SA
13.2.1 Instituto Grifols SA Company Information
13.2.2 Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.2.3 Instituto Grifols SA Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Instituto Grifols SA Main Business Overview
13.2.5 Instituto Grifols SA Latest Developments
13.3 CSL Behring LLC
13.3.1 CSL Behring LLC Company Information
13.3.2 CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.3.3 CSL Behring LLC Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 CSL Behring LLC Main Business Overview
13.3.5 CSL Behring LLC Latest Developments
13.4 KM Biologics KK
13.4.1 KM Biologics KK Company Information
13.4.2 KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.4.3 KM Biologics KK Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 KM Biologics KK Main Business Overview
13.4.5 KM Biologics KK Latest Developments
13.5 Baxter Healthcare Corp.
13.5.1 Baxter Healthcare Corp. Company Information
13.5.2 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.5.3 Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Baxter Healthcare Corp. Main Business Overview
13.5.5 Baxter Healthcare Corp. Latest Developments
13.6 Sanquin
13.6.1 Sanquin Company Information
13.6.2 Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.6.3 Sanquin Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Sanquin Main Business Overview
13.6.5 Sanquin Latest Developments
13.7 Johnson & Johnson
13.7.1 Johnson & Johnson Company Information
13.7.2 Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.7.3 Johnson & Johnson Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Johnson & Johnson Main Business Overview
13.7.5 Johnson & Johnson Latest Developments
13.8 Octapharma AG
13.8.1 Octapharma AG Company Information
13.8.2 Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.8.3 Octapharma AG Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Octapharma AG Main Business Overview
13.8.5 Octapharma AG Latest Developments
13.9 Bio Products Laboratory Ltd.
13.9.1 Bio Products Laboratory Ltd. Company Information
13.9.2 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.9.3 Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Bio Products Laboratory Ltd. Main Business Overview
13.9.5 Bio Products Laboratory Ltd. Latest Developments
13.10 Grifols Biologicals, Inc.
13.10.1 Grifols Biologicals, Inc. Company Information
13.10.2 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.10.3 Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Grifols Biologicals, Inc. Main Business Overview
13.10.5 Grifols Biologicals, Inc. Latest Developments
13.11 Pfizer Inc.
13.11.1 Pfizer Inc. Company Information
13.11.2 Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.11.3 Pfizer Inc. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Pfizer Inc. Main Business Overview
13.11.5 Pfizer Inc. Latest Developments
13.12 Intas Biopharmaceuticals Ltd.
13.12.1 Intas Biopharmaceuticals Ltd. Company Information
13.12.2 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.12.3 Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Intas Biopharmaceuticals Ltd. Main Business Overview
13.12.5 Intas Biopharmaceuticals Ltd. Latest Developments
13.13 Shandong Taibang Biological Products
13.13.1 Shandong Taibang Biological Products Company Information
13.13.2 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.13.3 Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Shandong Taibang Biological Products Main Business Overview
13.13.5 Shandong Taibang Biological Products Latest Developments
13.14 Sinopharm Group Shanghai Blood Products
13.14.1 Sinopharm Group Shanghai Blood Products Company Information
13.14.2 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.14.3 Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Sinopharm Group Shanghai Blood Products Main Business Overview
13.14.5 Sinopharm Group Shanghai Blood Products Latest Developments
13.15 SHANGHAI RAAS
13.15.1 SHANGHAI RAAS Company Information
13.15.2 SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.15.3 SHANGHAI RAAS Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 SHANGHAI RAAS Main Business Overview
13.15.5 SHANGHAI RAAS Latest Developments
13.16 China Resources Boya Bio-Pharmaceutical
13.16.1 China Resources Boya Bio-Pharmaceutical Company Information
13.16.2 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.16.3 China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 China Resources Boya Bio-Pharmaceutical Main Business Overview
13.16.5 China Resources Boya Bio-Pharmaceutical Latest Developments
13.17 Chengdu Rongsheng Pharmaceuticals
13.17.1 Chengdu Rongsheng Pharmaceuticals Company Information
13.17.2 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.17.3 Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Chengdu Rongsheng Pharmaceuticals Main Business Overview
13.17.5 Chengdu Rongsheng Pharmaceuticals Latest Developments
13.18 Yuanda Shuyang Pharmaceutical
13.18.1 Yuanda Shuyang Pharmaceutical Company Information
13.18.2 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.18.3 Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Yuanda Shuyang Pharmaceutical Main Business Overview
13.18.5 Yuanda Shuyang Pharmaceutical Latest Developments
13.19 HUALAN BIO
13.19.1 HUALAN BIO Company Information
13.19.2 HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
13.19.3 HUALAN BIO Non-recombinant Coagulation Factors Sales, Revenue, Price and Gross Margin (2021-2026)
13.19.4 HUALAN BIO Main Business Overview
13.19.5 HUALAN BIO Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Non-recombinant Coagulation Factors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-recombinant Coagulation Factors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Coagulation Factor VIII
Table 4. Major Players of Human Fibrinogen
Table 5. Major Players of Others
Table 6. Global Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 7. Global Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Table 8. Global Non-recombinant Coagulation Factors Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2021-2026)
Table 10. Global Non-recombinant Coagulation Factors Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Non-recombinant Coagulation Factors Sale by Application (2021-2026) & (K Units)
Table 12. Global Non-recombinant Coagulation Factors Sale Market Share by Application (2021-2026)
Table 13. Global Non-recombinant Coagulation Factors Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-recombinant Coagulation Factors Revenue Market Share by Application (2021-2026)
Table 15. Global Non-recombinant Coagulation Factors Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Non-recombinant Coagulation Factors Sales by Company (2021-2026) & (K Units)
Table 17. Global Non-recombinant Coagulation Factors Sales Market Share by Company (2021-2026)
Table 18. Global Non-recombinant Coagulation Factors Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2021-2026)
Table 20. Global Non-recombinant Coagulation Factors Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution and Sales Area
Table 22. Players Non-recombinant Coagulation Factors Products Offered
Table 23. Non-recombinant Coagulation Factors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-recombinant Coagulation Factors Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Non-recombinant Coagulation Factors Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-recombinant Coagulation Factors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-recombinant Coagulation Factors Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-recombinant Coagulation Factors Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-recombinant Coagulation Factors Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-recombinant Coagulation Factors Sales by Country (2021-2026) & (K Units)
Table 35. Americas Non-recombinant Coagulation Factors Sales Market Share by Country (2021-2026)
Table 36. Americas Non-recombinant Coagulation Factors Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 38. Americas Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 39. APAC Non-recombinant Coagulation Factors Sales by Region (2021-2026) & (K Units)
Table 40. APAC Non-recombinant Coagulation Factors Sales Market Share by Region (2021-2026)
Table 41. APAC Non-recombinant Coagulation Factors Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 43. APAC Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 44. Europe Non-recombinant Coagulation Factors Sales by Country (2021-2026) & (K Units)
Table 45. Europe Non-recombinant Coagulation Factors Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 47. Europe Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Non-recombinant Coagulation Factors Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-recombinant Coagulation Factors
Table 53. Key Market Challenges & Risks of Non-recombinant Coagulation Factors
Table 54. Key Industry Trends of Non-recombinant Coagulation Factors
Table 55. Non-recombinant Coagulation Factors Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-recombinant Coagulation Factors Distributors List
Table 58. Non-recombinant Coagulation Factors Customer List
Table 59. Global Non-recombinant Coagulation Factors Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Non-recombinant Coagulation Factors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-recombinant Coagulation Factors Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Non-recombinant Coagulation Factors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-recombinant Coagulation Factors Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Non-recombinant Coagulation Factors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-recombinant Coagulation Factors Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Non-recombinant Coagulation Factors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Non-recombinant Coagulation Factors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-recombinant Coagulation Factors Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Non-recombinant Coagulation Factors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-recombinant Coagulation Factors Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Non-recombinant Coagulation Factors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 75. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceutical Main Business
Table 77. Takeda Pharmaceutical Latest Developments
Table 78. Instituto Grifols SA Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 79. Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 80. Instituto Grifols SA Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Instituto Grifols SA Main Business
Table 82. Instituto Grifols SA Latest Developments
Table 83. CSL Behring LLC Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 85. CSL Behring LLC Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CSL Behring LLC Main Business
Table 87. CSL Behring LLC Latest Developments
Table 88. KM Biologics KK Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 89. KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 90. KM Biologics KK Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. KM Biologics KK Main Business
Table 92. KM Biologics KK Latest Developments
Table 93. Baxter Healthcare Corp. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 95. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Baxter Healthcare Corp. Main Business
Table 97. Baxter Healthcare Corp. Latest Developments
Table 98. Sanquin Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 100. Sanquin Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sanquin Main Business
Table 102. Sanquin Latest Developments
Table 103. Johnson & Johnson Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 105. Johnson & Johnson Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. Octapharma AG Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 109. Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 110. Octapharma AG Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Octapharma AG Main Business
Table 112. Octapharma AG Latest Developments
Table 113. Bio Products Laboratory Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 115. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Bio Products Laboratory Ltd. Main Business
Table 117. Bio Products Laboratory Ltd. Latest Developments
Table 118. Grifols Biologicals, Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 119. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 120. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Grifols Biologicals, Inc. Main Business
Table 122. Grifols Biologicals, Inc. Latest Developments
Table 123. Pfizer Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 124. Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 125. Pfizer Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Pfizer Inc. Main Business
Table 127. Pfizer Inc. Latest Developments
Table 128. Intas Biopharmaceuticals Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 129. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 130. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Intas Biopharmaceuticals Ltd. Main Business
Table 132. Intas Biopharmaceuticals Ltd. Latest Developments
Table 133. Shandong Taibang Biological Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 134. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 135. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Shandong Taibang Biological Products Main Business
Table 137. Shandong Taibang Biological Products Latest Developments
Table 138. Sinopharm Group Shanghai Blood Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 139. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 140. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Sinopharm Group Shanghai Blood Products Main Business
Table 142. Sinopharm Group Shanghai Blood Products Latest Developments
Table 143. SHANGHAI RAAS Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 144. SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 145. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. SHANGHAI RAAS Main Business
Table 147. SHANGHAI RAAS Latest Developments
Table 148. China Resources Boya Bio-Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 149. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 150. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. China Resources Boya Bio-Pharmaceutical Main Business
Table 152. China Resources Boya Bio-Pharmaceutical Latest Developments
Table 153. Chengdu Rongsheng Pharmaceuticals Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 154. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 155. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Chengdu Rongsheng Pharmaceuticals Main Business
Table 157. Chengdu Rongsheng Pharmaceuticals Latest Developments
Table 158. Yuanda Shuyang Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 159. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 160. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Yuanda Shuyang Pharmaceutical Main Business
Table 162. Yuanda Shuyang Pharmaceutical Latest Developments
Table 163. HUALAN BIO Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 164. HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 165. HUALAN BIO Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. HUALAN BIO Main Business
Table 167. HUALAN BIO Latest Developments
Table 1. Non-recombinant Coagulation Factors Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Non-recombinant Coagulation Factors Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Coagulation Factor VIII
Table 4. Major Players of Human Fibrinogen
Table 5. Major Players of Others
Table 6. Global Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 7. Global Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Table 8. Global Non-recombinant Coagulation Factors Revenue by Type (2021-2026) & ($ million)
Table 9. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2021-2026)
Table 10. Global Non-recombinant Coagulation Factors Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Non-recombinant Coagulation Factors Sale by Application (2021-2026) & (K Units)
Table 12. Global Non-recombinant Coagulation Factors Sale Market Share by Application (2021-2026)
Table 13. Global Non-recombinant Coagulation Factors Revenue by Application (2021-2026) & ($ million)
Table 14. Global Non-recombinant Coagulation Factors Revenue Market Share by Application (2021-2026)
Table 15. Global Non-recombinant Coagulation Factors Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Non-recombinant Coagulation Factors Sales by Company (2021-2026) & (K Units)
Table 17. Global Non-recombinant Coagulation Factors Sales Market Share by Company (2021-2026)
Table 18. Global Non-recombinant Coagulation Factors Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Non-recombinant Coagulation Factors Revenue Market Share by Company (2021-2026)
Table 20. Global Non-recombinant Coagulation Factors Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Non-recombinant Coagulation Factors Producing Area Distribution and Sales Area
Table 22. Players Non-recombinant Coagulation Factors Products Offered
Table 23. Non-recombinant Coagulation Factors Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Non-recombinant Coagulation Factors Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Non-recombinant Coagulation Factors Sales Market Share Geographic Region (2021-2026)
Table 28. Global Non-recombinant Coagulation Factors Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Non-recombinant Coagulation Factors Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2021-2026)
Table 32. Global Non-recombinant Coagulation Factors Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Non-recombinant Coagulation Factors Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Non-recombinant Coagulation Factors Sales by Country (2021-2026) & (K Units)
Table 35. Americas Non-recombinant Coagulation Factors Sales Market Share by Country (2021-2026)
Table 36. Americas Non-recombinant Coagulation Factors Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 38. Americas Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 39. APAC Non-recombinant Coagulation Factors Sales by Region (2021-2026) & (K Units)
Table 40. APAC Non-recombinant Coagulation Factors Sales Market Share by Region (2021-2026)
Table 41. APAC Non-recombinant Coagulation Factors Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 43. APAC Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 44. Europe Non-recombinant Coagulation Factors Sales by Country (2021-2026) & (K Units)
Table 45. Europe Non-recombinant Coagulation Factors Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 47. Europe Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Non-recombinant Coagulation Factors Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Non-recombinant Coagulation Factors Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Non-recombinant Coagulation Factors Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Non-recombinant Coagulation Factors Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Non-recombinant Coagulation Factors
Table 53. Key Market Challenges & Risks of Non-recombinant Coagulation Factors
Table 54. Key Industry Trends of Non-recombinant Coagulation Factors
Table 55. Non-recombinant Coagulation Factors Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Non-recombinant Coagulation Factors Distributors List
Table 58. Non-recombinant Coagulation Factors Customer List
Table 59. Global Non-recombinant Coagulation Factors Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Non-recombinant Coagulation Factors Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Non-recombinant Coagulation Factors Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Non-recombinant Coagulation Factors Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Non-recombinant Coagulation Factors Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Non-recombinant Coagulation Factors Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Non-recombinant Coagulation Factors Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Non-recombinant Coagulation Factors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Non-recombinant Coagulation Factors Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Non-recombinant Coagulation Factors Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Non-recombinant Coagulation Factors Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Non-recombinant Coagulation Factors Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Non-recombinant Coagulation Factors Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Takeda Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 74. Takeda Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 75. Takeda Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Takeda Pharmaceutical Main Business
Table 77. Takeda Pharmaceutical Latest Developments
Table 78. Instituto Grifols SA Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 79. Instituto Grifols SA Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 80. Instituto Grifols SA Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Instituto Grifols SA Main Business
Table 82. Instituto Grifols SA Latest Developments
Table 83. CSL Behring LLC Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 84. CSL Behring LLC Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 85. CSL Behring LLC Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. CSL Behring LLC Main Business
Table 87. CSL Behring LLC Latest Developments
Table 88. KM Biologics KK Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 89. KM Biologics KK Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 90. KM Biologics KK Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. KM Biologics KK Main Business
Table 92. KM Biologics KK Latest Developments
Table 93. Baxter Healthcare Corp. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 94. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 95. Baxter Healthcare Corp. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Baxter Healthcare Corp. Main Business
Table 97. Baxter Healthcare Corp. Latest Developments
Table 98. Sanquin Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 99. Sanquin Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 100. Sanquin Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Sanquin Main Business
Table 102. Sanquin Latest Developments
Table 103. Johnson & Johnson Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 104. Johnson & Johnson Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 105. Johnson & Johnson Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. Johnson & Johnson Main Business
Table 107. Johnson & Johnson Latest Developments
Table 108. Octapharma AG Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 109. Octapharma AG Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 110. Octapharma AG Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Octapharma AG Main Business
Table 112. Octapharma AG Latest Developments
Table 113. Bio Products Laboratory Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 114. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 115. Bio Products Laboratory Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Bio Products Laboratory Ltd. Main Business
Table 117. Bio Products Laboratory Ltd. Latest Developments
Table 118. Grifols Biologicals, Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 119. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 120. Grifols Biologicals, Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Grifols Biologicals, Inc. Main Business
Table 122. Grifols Biologicals, Inc. Latest Developments
Table 123. Pfizer Inc. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 124. Pfizer Inc. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 125. Pfizer Inc. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Pfizer Inc. Main Business
Table 127. Pfizer Inc. Latest Developments
Table 128. Intas Biopharmaceuticals Ltd. Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 129. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 130. Intas Biopharmaceuticals Ltd. Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. Intas Biopharmaceuticals Ltd. Main Business
Table 132. Intas Biopharmaceuticals Ltd. Latest Developments
Table 133. Shandong Taibang Biological Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 134. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 135. Shandong Taibang Biological Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Shandong Taibang Biological Products Main Business
Table 137. Shandong Taibang Biological Products Latest Developments
Table 138. Sinopharm Group Shanghai Blood Products Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 139. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 140. Sinopharm Group Shanghai Blood Products Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 141. Sinopharm Group Shanghai Blood Products Main Business
Table 142. Sinopharm Group Shanghai Blood Products Latest Developments
Table 143. SHANGHAI RAAS Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 144. SHANGHAI RAAS Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 145. SHANGHAI RAAS Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 146. SHANGHAI RAAS Main Business
Table 147. SHANGHAI RAAS Latest Developments
Table 148. China Resources Boya Bio-Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 149. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 150. China Resources Boya Bio-Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 151. China Resources Boya Bio-Pharmaceutical Main Business
Table 152. China Resources Boya Bio-Pharmaceutical Latest Developments
Table 153. Chengdu Rongsheng Pharmaceuticals Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 154. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 155. Chengdu Rongsheng Pharmaceuticals Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 156. Chengdu Rongsheng Pharmaceuticals Main Business
Table 157. Chengdu Rongsheng Pharmaceuticals Latest Developments
Table 158. Yuanda Shuyang Pharmaceutical Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 159. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 160. Yuanda Shuyang Pharmaceutical Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 161. Yuanda Shuyang Pharmaceutical Main Business
Table 162. Yuanda Shuyang Pharmaceutical Latest Developments
Table 163. HUALAN BIO Basic Information, Non-recombinant Coagulation Factors Manufacturing Base, Sales Area and Its Competitors
Table 164. HUALAN BIO Non-recombinant Coagulation Factors Product Portfolios and Specifications
Table 165. HUALAN BIO Non-recombinant Coagulation Factors Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 166. HUALAN BIO Main Business
Table 167. HUALAN BIO Latest Developments
LIST OF FIGURES
Figure 1. Picture of Non-recombinant Coagulation Factors
Figure 2. Non-recombinant Coagulation Factors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-recombinant Coagulation Factors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-recombinant Coagulation Factors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-recombinant Coagulation Factors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2025)
Figure 10. Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Coagulation Factor VIII
Figure 12. Product Picture of Human Fibrinogen
Figure 13. Product Picture of Others
Figure 14. Global Non-recombinant Coagulation Factors Sales Market Share by Type in 2026
Figure 15. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2021-2026)
Figure 16. Non-recombinant Coagulation Factors Consumed in Hemophilia
Figure 17. Global Non-recombinant Coagulation Factors Market: Hemophilia (2021-2026) & (K Units)
Figure 18. Non-recombinant Coagulation Factors Consumed in Fibrinogen Deficiency
Figure 19. Global Non-recombinant Coagulation Factors Market: Fibrinogen Deficiency (2021-2026) & (K Units)
Figure 20. Non-recombinant Coagulation Factors Consumed in Other
Figure 21. Global Non-recombinant Coagulation Factors Market: Other (2021-2026) & (K Units)
Figure 22. Global Non-recombinant Coagulation Factors Sale Market Share by Application (2025)
Figure 23. Global Non-recombinant Coagulation Factors Revenue Market Share by Application in 2026
Figure 24. Non-recombinant Coagulation Factors Sales by Company in 2026 (K Units)
Figure 25. Global Non-recombinant Coagulation Factors Sales Market Share by Company in 2026
Figure 26. Non-recombinant Coagulation Factors Revenue by Company in 2026 ($ millions)
Figure 27. Global Non-recombinant Coagulation Factors Revenue Market Share by Company in 2026
Figure 28. Global Non-recombinant Coagulation Factors Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 31. Americas Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 32. APAC Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 33. APAC Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 34. Europe Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 35. Europe Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 38. Americas Non-recombinant Coagulation Factors Sales Market Share by Country in 2026
Figure 39. Americas Non-recombinant Coagulation Factors Revenue Market Share by Country (2021-2026)
Figure 40. Americas Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 41. Americas Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 42. United States Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Non-recombinant Coagulation Factors Sales Market Share by Region in 2026
Figure 47. APAC Non-recombinant Coagulation Factors Revenue Market Share by Region (2021-2026)
Figure 48. APAC Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 49. APAC Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 50. China Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 54. India Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Non-recombinant Coagulation Factors Sales Market Share by Country in 2026
Figure 58. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country (2021-2026)
Figure 59. Europe Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 60. Europe Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 61. Germany Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 62. France Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 69. Egypt Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors in 2026
Figure 75. Manufacturing Process Analysis of Non-recombinant Coagulation Factors
Figure 76. Industry Chain Structure of Non-recombinant Coagulation Factors
Figure 77. Channels of Distribution
Figure 78. Global Non-recombinant Coagulation Factors Sales Market Forecast by Region (2027-2032)
Figure 79. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Non-recombinant Coagulation Factors
Figure 2. Non-recombinant Coagulation Factors Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-recombinant Coagulation Factors Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Non-recombinant Coagulation Factors Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Non-recombinant Coagulation Factors Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2025)
Figure 10. Non-recombinant Coagulation Factors Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Coagulation Factor VIII
Figure 12. Product Picture of Human Fibrinogen
Figure 13. Product Picture of Others
Figure 14. Global Non-recombinant Coagulation Factors Sales Market Share by Type in 2026
Figure 15. Global Non-recombinant Coagulation Factors Revenue Market Share by Type (2021-2026)
Figure 16. Non-recombinant Coagulation Factors Consumed in Hemophilia
Figure 17. Global Non-recombinant Coagulation Factors Market: Hemophilia (2021-2026) & (K Units)
Figure 18. Non-recombinant Coagulation Factors Consumed in Fibrinogen Deficiency
Figure 19. Global Non-recombinant Coagulation Factors Market: Fibrinogen Deficiency (2021-2026) & (K Units)
Figure 20. Non-recombinant Coagulation Factors Consumed in Other
Figure 21. Global Non-recombinant Coagulation Factors Market: Other (2021-2026) & (K Units)
Figure 22. Global Non-recombinant Coagulation Factors Sale Market Share by Application (2025)
Figure 23. Global Non-recombinant Coagulation Factors Revenue Market Share by Application in 2026
Figure 24. Non-recombinant Coagulation Factors Sales by Company in 2026 (K Units)
Figure 25. Global Non-recombinant Coagulation Factors Sales Market Share by Company in 2026
Figure 26. Non-recombinant Coagulation Factors Revenue by Company in 2026 ($ millions)
Figure 27. Global Non-recombinant Coagulation Factors Revenue Market Share by Company in 2026
Figure 28. Global Non-recombinant Coagulation Factors Sales Market Share by Geographic Region (2021-2026)
Figure 29. Global Non-recombinant Coagulation Factors Revenue Market Share by Geographic Region in 2026
Figure 30. Americas Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 31. Americas Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 32. APAC Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 33. APAC Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 34. Europe Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 35. Europe Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 36. Middle East & Africa Non-recombinant Coagulation Factors Sales 2021-2026 (K Units)
Figure 37. Middle East & Africa Non-recombinant Coagulation Factors Revenue 2021-2026 ($ millions)
Figure 38. Americas Non-recombinant Coagulation Factors Sales Market Share by Country in 2026
Figure 39. Americas Non-recombinant Coagulation Factors Revenue Market Share by Country (2021-2026)
Figure 40. Americas Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 41. Americas Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 42. United States Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 43. Canada Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 44. Mexico Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 45. Brazil Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 46. APAC Non-recombinant Coagulation Factors Sales Market Share by Region in 2026
Figure 47. APAC Non-recombinant Coagulation Factors Revenue Market Share by Region (2021-2026)
Figure 48. APAC Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 49. APAC Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 50. China Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 51. Japan Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 52. South Korea Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 53. Southeast Asia Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 54. India Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 55. Australia Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 56. China Taiwan Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 57. Europe Non-recombinant Coagulation Factors Sales Market Share by Country in 2026
Figure 58. Europe Non-recombinant Coagulation Factors Revenue Market Share by Country (2021-2026)
Figure 59. Europe Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 60. Europe Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 61. Germany Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 62. France Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 63. UK Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 64. Italy Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 65. Russia Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 66. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Country (2021-2026)
Figure 67. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Type (2021-2026)
Figure 68. Middle East & Africa Non-recombinant Coagulation Factors Sales Market Share by Application (2021-2026)
Figure 69. Egypt Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 70. South Africa Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 71. Israel Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 72. Turkey Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 73. GCC Countries Non-recombinant Coagulation Factors Revenue Growth 2021-2026 ($ millions)
Figure 74. Manufacturing Cost Structure Analysis of Non-recombinant Coagulation Factors in 2026
Figure 75. Manufacturing Process Analysis of Non-recombinant Coagulation Factors
Figure 76. Industry Chain Structure of Non-recombinant Coagulation Factors
Figure 77. Channels of Distribution
Figure 78. Global Non-recombinant Coagulation Factors Sales Market Forecast by Region (2027-2032)
Figure 79. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Region (2027-2032)
Figure 80. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Type (2027-2032)
Figure 81. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Type (2027-2032)
Figure 82. Global Non-recombinant Coagulation Factors Sales Market Share Forecast by Application (2027-2032)
Figure 83. Global Non-recombinant Coagulation Factors Revenue Market Share Forecast by Application (2027-2032)
